BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Saeki Y, Sawaguchi J, Akita S, Takamura TA, Fujibayashi K, Wakasa M, Akao H, Kitayama M, Kawai Y, Kajinami K. Initial decrease in the lipoprotein(a) level is a novel prognostic biomarker in patients with acute coronary syndrome. World J Cardiol 2024; 16(6): 329-338 [PMID: 38993583 DOI: 10.4330/wjc.v16.i6.329]
URL: https://www.wjgnet.com/1949-8462/full/v16/i6/329.htm
Number Citing Articles
1
Azad Mojahedi, On Chen, Hal A Skopicki, Tahmid Rahman, Amirhossein Sadeghian. Lipoprotein(a) as a Predictor of Cardiovascular Risk in Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Systematic ReviewReviews in Cardiovascular Medicine 2025; 26(9) doi: 10.31083/RCM42784
2
George Thanassoulis, Sonia Anand, Benoit J. Arsenault, Kevin R. Bainey, Alan D. Bell, Liam R. Brunham, Iulia Iatan, Marlys L. Koschinsky, Lawrence A. Leiter, Shamir R. Mehta, A.Shekhar Pandey, Glen J. Pearson. Clinical care for patients with elevated lipoprotein(a) in Canada: a practical framework for screening, risk assessment and management.Canadian Journal of Cardiology 2026;  doi: 10.1016/j.cjca.2025.12.060